Vascular endothelial growth factor antagonist reduces the early onset and the severity of ovarian hyperstimulation syndrome

Autor: Jellad, S., Haj Hassine, A., Basly, M., Mrabet, A., Chibani, M., Rachdi, R.
Zdroj: Journal de Gynécologie Obstétrique et Biologie de la Reproduction; 20240101, Issue: Preprints
Abstrakt: Ovarian hyperstimulation syndrome (OHSS) is the most serious complication of controlled ovarian stimulation (COH) during assisted reproductive technology (ART) protocols. This syndrome is a result of ovarian expression of vascular endothelial growth factor (VEGF), which increases vascular permeability.
Databáze: Supplemental Index